Efficacy and Safety in Transfusion Independent Non-severe Aplastic Anemia

NCT05399732 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Aplastic Anemia

Interventions

DRUG: Luspatercept
DRUG: Cyclosporine

Sponsor

Bing Han

Collaborators

[object Object]